Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer

被引：0
|
作者：
Silvia Cantara
Eugenio Bertelli
Rossella Occhini
Marì Regoli
Lucia Brilli
Furio Pacini
Maria Grazia Castagna
Paolo Toti
机构：
[1] University of Siena,Department of Medical, Surgical and Neurological Sciences
[2] University of Siena,Department of Molecular and Developmental Medicine
[3] Arezzo Hospital,Unit of Pathology
[4] University of Siena,undefined
来源：
Endocrine | 2019年 / 64卷
关键词：
PD-L1; PD-1; Anaplastic thyroid cancer; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：122 / 129
页数：7
相关论文
共 50 条
  • [1] Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer
    Cantara, Silvia
    Bertelli, Eugenio
    Occhini, Rossella
    Regoli, Mari
    Brilli, Lucia
    Pacini, Furio
    Castagna, Maria Grazia
    Toti, Paolo
    ENDOCRINE, 2019, 64 (01) : 122 - 129
  • [2] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Lathika, Aryakrishna S.
    Lakshmi, S.
    Ramdas, Preethi T.
    Kumar, Aswin
    Mathews, Susan
    Joseph, John
    Mathew, Aleyamma
    James, Francis V.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
  • [3] The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy
    Zhang, Lifang
    Zhao, Yu
    Tu, Quanmei
    Xue, Xiangyang
    Zhu, Xueqiong
    Zhao, Kong-Nan
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (05) : 893 - 909
  • [4] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Aryakrishna S. Lathika
    S. Lakshmi
    Preethi T. Ramdas
    Aswin Kumar
    Susan Mathews
    John Joseph
    Aleyamma Mathew
    Francis V. James
    Indian Journal of Gynecologic Oncology, 2021, 19
  • [5] Recent advances in atezolizumab-based programmed death-ligand 1 (PD-L1) blockade therapy for breast cancer
    Ameri, Ali
    Tavakoli-Far, Bahareh
    Rostami, Maryam
    Kiasari, Bahman Abedi
    Sakhaei, Delaram
    Ahmed, Omar Saad
    Forouzani, Fatemeh
    Fazli, Yasaman
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [6] Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade A Key Player Against Various Cancers
    Guan, Jian
    Lim, Khin Sandar
    Mekhail, Tarek
    Chang, Chung-Che
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (06) : 851 - 861
  • [7] Predictive markers for programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) axis blockade therapy in patients with metastatic melanoma (MM).
    Kim, Dae Won
    Chakravarti, Nitin
    Trinh, VanAnh
    Perdon, Karen Mae
    McIntyre, Susan E.
    Prieto, Victor G.
    Hwu, Wen-Jen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Programmed death ligand 1 (PD-L1) expression and tumor infiltrating lymphocytes in diffuse and anaplastic gliomas
    Berghoff, A. S.
    Kiesel, B.
    Widhalm, G.
    Rajky, O.
    Ricken, G.
    Woehrer, A.
    Dieckmann, K.
    Zielinski, C. C.
    Marosi, C.
    Preusser, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S593 - S593
  • [9] TUMOR INFILTRATING LYMPHOCYTES AND PROGRAMMED DEATH LIGAND 1 (PD-L1) EXPRESSION IN DIFFUSE AND ANAPLASTIC GLIOMAS
    Berghoff, A. S.
    Kiesel, B.
    Widhalm, G.
    Wilhelm, D.
    Rajky, O.
    Kurscheid, S.
    Hegi, M.
    Woehrer, A.
    Marosi, C.
    Preusser, M.
    NEURO-ONCOLOGY, 2016, 18 : 26 - 26
  • [10] Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer
    Wang, Lisha
    Ren, Fei
    Wang, Qifeng
    Baldridge, Lee Ann
    Monn, M. Francesca
    Fisher, Kurt W.
    Sheng, Weiqi
    Zhou, Xiaoyan
    Du, Xiang
    Cheng, Liang
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (02) : 175 - 181
12345